Patents by Inventor Barbara E. Loughman

Barbara E. Loughman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4450159
    Abstract: Novel cyclized .omega.-carboxyethyl mono or dithiocarbanilic acids are disclosed as immunoregulatory agents, useful in the treatment of organ transplant reject phenomenon and autoimmune diseases particularly where a delayed hypersensitivity component has been established, such as multiple sclerosis.Additionally described is the use of certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids and certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids.
    Type: Grant
    Filed: August 8, 1979
    Date of Patent: May 22, 1984
    Assignee: The Upjohn Company
    Inventors: David J. Anderson, Barbara E. Loughman
  • Patent number: 4352929
    Abstract: Novel cyclized .omega.-carboxyethyl mono- or dithiocarbanilic acids are disclosed as immunoregulatory agents, useful in the treatment of organ transplant reject phenomenon and autoimmune diseases particularly where a delayed hypersensitivity component has been established, such as multiple sclerosis.Additionally described is the use of certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids and certain cyclized .omega.-carboxyalkyl mono- or dithiocarbamic acids.
    Type: Grant
    Filed: May 29, 1981
    Date of Patent: October 5, 1982
    Assignee: The Upjohn Company
    Inventors: David J. Anderson, Barbara E. Loughman
  • Patent number: 4254142
    Abstract: Norbornyl thio- and dithiocarbanilic acid are described. The compounds possess immunoregulatory activity. Also provided are compositions containing and methods of using them.
    Type: Grant
    Filed: August 8, 1979
    Date of Patent: March 3, 1981
    Assignee: The Upjohn Company
    Inventors: David J. Anderson, Barbara E. Loughman